Hip Replacement Implant Market to Become Worth US$9.1 bn by 2024

According to a new study by Transparency Market Research (TMR), the global hip replacement implant market demonstrates a highly competitive and fragmented structure, thanks to the presence of a number of established vendors of hip replacement implants across the world. The leading participants in this market are B. Braun Melsungen AG, DJO Global, Inc., Zimmer Biomet Holdings, Inc., Exactech, Inc., Johnson & Johnson, OMNIlife science, Inc., MicroPort Scientific Corporation, Smith & Nephew, and Stryker Corporation. For the sustenance in this competitive environment, these players are focusing on technological advancements and expanding their regional boundaries. Innovation and price differentiations are also being kept in focus by these participants to gain an edge over their rivals, states the research report.

Read Report Overview: https://www.transparencymarketresearch.com/hip-replacement-implants-market.html

Global Hip Replacement Implant Market to Report 3.90% CAGR between 2016 and 2024

As per the study, the worldwide market for hip replacement implant, which stood at US$6.5 bn in 2015, is anticipated to proliferate at a CAGR of 3.90% during the period from 2016 to 2024. The valuation of this market is likely to touch US$9.1 bn by the end of the period of the forecast. Currently, the total hip replacement implants segment is enjoying the most prominent position in this market and analysts expect that this trend is likely to continue over the next few years. Hospitals have surfaced as the leading end user of hip replacement implants across the world. The scenario is projected to remain like this over the forthcoming years.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1901

In terms of the region, North America emerged as the leading regional market for hip replacement implant in 2015. With a revenue share of 52.7% in the global market, this regional market is anticipated to remain on the top by the end of the forecast period, reports the market study.

Increasing Number of Elderly People to Boost Market

“The global market for hip replacement implants gains significantly from the increasing base of geriatric population across the world, as elderly people is the more prone to weakening of bones, resulting into joint-related problems, says the author of this study. The rising incidence of accidents and the increasing prevalence of osteoarthritis are also propelling this market tremendously.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1901

Going forward, the market is likely to benefit from the technological advancements in hip replacement implants substantially. The increasing investments for research and development activities in this field are also projected to boost this market in the near future. On the flip side, the expensiveness hip replacement implants is expected to hold back this market over the next few years. The high cost incurred in the treatment and post-surgical maintenance is also projected to slow down the growth of this market to some extent, states the research report.

Medical Image Analysis Software Market Opportunity will Rise to US$4.66 bn by 2024

According to Transparency Market Research, the market is foreseen to experience significant growth with a strong CAGR of 8.10% within the forecast period, to attain a value of US$4.66 bn by 2024. Geographically, North America leads the race and in 2015 held 34% of overall market shares.

Rising Trend of Using of EHR to Propel Demand of Medical Image Analysis Software

Owing to rise in number of chronic illness around the world, the demand for medical image analysis software is a rising. Furthermore, the trend of utilizing electronic health records to store, circulate and manage patient’s health information as medical images is also boosting the medical image analysis software market. Besides, as a result of constant medical innovations, for example, computer aided diagnosis, there is a scope for tremendous progress in the usage of new and improved medical image software devices supporting in the treatment of a various types of sicknesses like tumor.

Read Report Overview: https://www.transparencymarketresearch.com/medical-image-analysis-software-market.html

In the medical image analysis, the health related issues are examined with the help of computerized image and different other imaging modalities. Medical image analysis software is used to improve the adequacy and proficiency of medical treatment. The upsides of utilizing such kind of software are upgraded image quality, high determination of images and multi-modular imaging stages which are favored by doctors. It also enables sharing of medical image records among specialists and healing centers thereby making the task of diagnosing and treating much easier. These are the components driving the worldwide medical image analysis software market.

Increase in Investments by Public and Private Firm to Fuel Overall Market Growth

The development of the market is credited to progress in medical imaging frameworks and analysis software, private and public investments in the medical imaging market, expanding utilization of imaging devices because of increase in the cases of chronic ailments, and rising uses of computer aided diagnosis. Developing requirement for automated image analysis devices, rising acceptance of cloud-based imaging systems, and undiscovered developing markets are expected to offer critical development scope for manufacturers in the coming few years.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5306

With the emergence of various leading players the overall medical image analysis software market exhibits an exceptionally fragmented landscape. Some of the prominent participants in the market are Siemens Healthineers, GE Healthcare, Hologic Inc., Pie Medical Imaging, Agfa-Gevaert N.V., Carestream Health, Inc., AQUILAB, Esaote SpA, Philips Healthcare, Sciencesoft USA Corporation, Mirada Medical Limited, Analogic Corporation, Merge Healthcare Inc., and Toshiba Medical Systems Corporation. These players, all things considered, are foreseen to account for 23.5% of the entire market in year in 2015. The report likewise profiles organizations that are predicted to stay dynamic in the worldwide medical image analysis software market till 2022. As of now, organizations are effectively engaged with product development to gain a competitive edge over their companions. Nevertheless, an attempt towards mergers and collaborations can be seen over the coming years.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5306

Prostate Cancer Therapeutics Market Opportunity will Rise to US$ 17.53 bn by 2024

According to estimates presented by TMR, the global prostate cancer therapeutics market is likely to clock a CAGR of 8.19% between 2017 and 2024 vis-à-vis revenue. At this rate, the opportunities in the market are expected to be worth US$17,535.3 mn by the end of 2024 from US$10,107.6 mn in 2017. By therapy type, hormone therapy is currently most attractive and is predicted to stay this way over the forecast period. Hospital pharmacy is the leading distribution channel segment as it stocks various medicines needed at different stage of treatment.

Read Report Overview: https://www.transparencymarketresearch.com/prostate-cancer-therapeutics-market.html

Launch of New Treatment Options Stimulates Growth

Majorly fuelling the global prostate cancer therapeutics market is rising incidence of prostate cancer. As per data published by Cancer Research - a U.K. based government institute, 11,287 prostate cancer deaths were reported in the country in 2014. Prostate cancer is a serious health condition among men that impacts quality of life to a high degree. Although the real cause of prostate cancer remains unknown, obesity and past history of cancer are some key factors associated with the condition. Regular screening, early diagnosis, and advances in medical science have enabled increased survival rate of prostate cancer.
Advances in medical science leading to launch of promising treatment options is fuelling the prostate cancer therapeutics market. Various diagnostic techniques have enabled detection of prostate cancer at an early stage. Measurement of prostate-specific antigen (PSA) has enabled early detection of prostate cancer. Some other promising therapies in phase II and phase III clinical trials for prostate cancer detection include hormonal agents, cytotoxic agents, and other antiprostate-specific membrane antigen therapies.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6562

Furthermore, as per the Mayo Foundation for Medical Education and Research, a combination of anti-cytotoxic T-lymphocyte-associated antigen and hormonal therapies can stir targeted immune response against prostate tumors.

Development of new drugs and novel therapeutic biological products are aiding the prostate cancer therapeutics market. Prominent players are aggressively engaged in R&D for developing novel therapeutics to enhance survival rate of prostate cancer patients. At present, several molecular agents are in early phase clinical trials for the treatment of prostate cancer. In addition, high adoption of hormone-refractory prostate cancer drug due to fewer side effects is providing new prospects to prostate cancer therapeutics market.
Apart from this, in developed countries, increased life expectancy has led to the rise in geriatric population that are at higher risk of developing prostate cancer. Hence, growing geriatric population along with sedentary lifestyle are some prime factors behind increasing prevalence of prostate cancer.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6562

High Cost of Targeted Therapies Make them Unaffordable

On the other hand, high cost of treatment of prostate cancer is holding back the growth of the prostate cancer therapeutics market. High costs of targeted therapies and other immunotherapies is unaffordable by a large population especially in developing and underdeveloped economies. In addition, reluctance toward adoption of premium treatments is another factor challenging the market’s growth. Most oncologists do not opt for systemic therapies for early state prostate cancer due to negative perception toward systemic therapy.

The global prostate cancer therapeutics market is highly consolidated with a handful of large players, namely Pfizer Inc., Janssen Biotech Inc., and Amgen that hold majority market share, says Transparency Market Research (TMR) in a new market study. These companies are engaged in research and development, manufacture, and commercial availability of new drugs. Acquisitions and strategic alliances are some other growth strategies adopted by key players in the prostate cancer therapeutics market. For example, in 2016, Pfizer Inc. announced the successful completion of acquisition of Medivation Inc., the latter’s portfolio includes Xtandi – a leading hormone therapy in the U.S. 

Physiotherapy Devices Market to Become Worth US$2,838.9 mn by 2025

Transparency Market Research produced a report that estimates the progress of the market along key parameters. It is prognosticated that the market value would elevate to US$2,838.9 mn by the end of 2025 as compared to a value of US$1,686.1 mn in 2016. These robust growth figures are expected to reap a CAGR of 6.1% over the period from 2017 to 2025. Based on the type of products available in the market, the electrotherapy equipment is likely to dominate the segment due to its expansive usage. Along regional lines, North America is expected attain supremacy over all other players during the forecast period.

Read Report Overview: https://www.transparencymarketresearch.com/physiotherapy-devices-market.html

Increase in Strenuous Activities and Ailments of Geriatric Populace to Bolster Market

Physiotherapies are an effective option to treat a medley of disabilities and neurological disorder, which is the prime reason behind the popularity of physiotherapy devices. The instance of musculoskeletal diseases has risen in recent years that has created room for these devices across various public healthcare units and private hospitals. The entire world is now driven towards engaging in sportive endeavors that has increased the possibility physical injuries, thus, escalating the demand within the market. The prevalence of neurological disorders and muscular amongst the geriatric populace calls for physiotherapies due to their non-intrusive nature. Henceforth, the growing geriatric population is also skyrocketing the demand for these products. Due to the relative effectiveness of these therapies as against surgical treatments, the medical practitioners have also been recommending physiotherapies to patients.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28517
Advancements in physiotherapy devices has instilled renewed hopes amongst people disables for prolonged periods of time, which is another important standpoint for the growth of the market. A number of healthcare centers have surfaced across the globe that inhabit the patients in their premises and administer long-term physiotherapy plans. This has propelled the growth of the market across the globe and has spiked up opportunities for market players.

Lack of Skilled Therapists Leads to Distrust Amongst Patients

Physiotherapy devices are technologically advanced which means that the therapists require palpable knowledge to operate them. The lack of skilled physiotherapists has placed a negative toll upon the market, especially in the developing economies. Moreover, the apprehensions associated with the lack of knowledge amongst the physiotherapists has given rise to distrust amongst the patients. Another hindrance for the global market is the high cost of these devices that holds back several practitioners to install these devices within their framework. However, in the absence of viable alternatives, the devices are expected to gain popularity and perpetuate market growth.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28517

The global physiotherapy devices market is anticipated to experience a prominent surge in demand over the coming years. Hence, the market players want to optimize the lucrativeness of their operations within the market by resorting to a range of business strategies. The coexistence of huge market players with several local and regional vendors has birthed intense competition within the market. To retain their dominance and gain a greater market share, the well-established players are aiming to differentiate their products from the products developed by competitors. Moreover, the market would excavate positive results for market player who succeed in dispelling innovative products at affordable prices. Mergers and acquisitions are expected to define the crux of the market as a large number of international players incline towards these strategies. The contemporary players in the market include Dynatronics Corporation, EMS Physio Ltd., BTL, DJO Global, Patterson Medical Ltd.,and Enraf-Nonius.

Tumor Ablation Market to Become Worth US$1.9 bn by 2024

A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market to witness a healthy growth rate of 12.20% during the forecast period of 2016 to 2024, reaching an estimated valuation of US$1.9 bn by 2024, considerably up from its evaluated worth of US$702.9 mn in 2015.

Read Report Overview: https://www.transparencymarketresearch.com/tumor-ablation-market.html

Among the key vendors currently operating in the global tumor ablation market, is Medtronic plc. The company has a diverse product portfolio and continues to add new products as well as enhances the successful ones. Geographical expansion has also helped Medtronic to gain ground over its competitors. In the near future, some of the other prominent companies, such as Ethicon, Boston Scientific, and AngioDynamics, are expected to depend on product innovation to stay afloat in the fragmented and competitive landscape.

Radiofrequency Ablation Profitable Technology Segment

Technology-wise, this report segments the global tumor ablation market into microwave ablation, laser interstitial thermal ablation, high-intensity focused ultrasound, and radiofrequency ablation, which currently is the most profitable segment. The demand for radiofrequency segment is projected for a CAGR of 10.90% during the forecast period of 2016 to 2024, significantly exceeding the overall growth rate of the market for tumor ablation. This substantial demand for tumor ablation is a reflection of several benefits offered by the procedure, which is efficient, causes nominal damage to the tissues, and offers high-density focused ultrasound.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18656

Based on material, the report segments the global tumor ablation market into cancers of liver, lung, kidney, bone, breast, and prostate. Liver cancer is more common among men than women, and has significant demand, although lung cancer category is high profitable too, primarily as a result of changing lifestyle among the urban population.

North America Remains Highly Profitable

Out of five regions analyzed by the report: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, the former accounted for nearly a third (30%) of the global demand in the tumor ablation market. In the near future, North America will continue to be the most lucrative region, gaining traction from factors such as high adoption rate of new technology, robust healthcare infrastructure, escalating geriatric population percentage, and high prevalence of cancer. Europe is another profitable region, although vastly populated Asia Pacific will turn into a highly profitable region as the technology goes cheaper and reaches widespread unmet demands.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18656

Prevalence of Cancer Driving Demand

A number of factors are ensuring the prosperity of the global tumor ablation market in the near future, such as growing geriatric population across the world, technological advancements in ablation devices, increasing population base of cancer patients, which is a chronic disease, mushrooming number of hospitals, ablation centers, and surgical facilities across the globe, changing lifestyle, and government benefits for the companies indulging the in the research and development in this field. On the other hand, while cost constraints continue to hinder the proper progress of the market for tumor ablation, ongoing healthcare reforms is not supporting the current inflow of the demand.

Patient Engagement Solutions Market is Expanding at a CAGR of 23.0% by 2023

Global Patient Engagement Solutions Market: Snapshot
The global patient engagement solutions market has been witnessing a remarkable rise in its valuation as well as size. With the increasing prevalence of chronic diseases and a significant growth in the global geriatric population, the need for patient-oriented healthcare services has increased, leading to an augmented demand for patient engagement solutions, across the world. In addition to this, the rising uptake of IT in healthcare services is likely to aid this market considerably over the coming years.

In 2014, the overall opportunity in the global patient engagement solutions market was US$6.6 bn. Proliferating at a remarkable CAGR of 23.0% during the period from 2015 to 2023, the market is anticipated to reach US$34.9 bn by the end of 2023.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4506

Application-managed Services to Witness High-paced Growth

The global market for patient engagement solutions is analyzed on the basis of delivery mode and the end user. Based on the delivery mode, the market is classified into self-hosted services, application-managed services, and software as a service (SaaS). Among these, the demand for self-hosted solutions is higher than the other two at present. However, the application-managed services segment is projected to witness a high-paced growth over the next few years, thanks to the easy access and on-the-go services provided by this segment.

By the end user, the market is categorized into hospitals and healthcare providers, pharmaceutical companies, and medical and healthcare payers. Of these, hospital and healthcare providers have emerged as the key end user of patient engagement solutions and are expected to continue like this over the forthcoming years.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4506

Pharmaceutical companies, on the other hand, are anticipated to display promising growth opportunities over the next few years, as a large pool of pharma companies are expected to uptake patient engagement solutions in order to meet their research and development requirements and control the operational capital incurred. The tremendous increase in the interest of pharmaceutical companies in patient engagement solutions is due to the feedbacks from patients and physicians regarding the prescribed drugs from these solutions, which plays a crucial role for these companies in improving their existing and pipeline products.

Read Report Overview: https://www.transparencymarketresearch.com/patient-engagement-solutions-market.html

North America to Retain Dominance

The global market for patient engagement solutions reports its presence across the Middle East and Africa, Latin America, Asia Pacific, Europe, and North America. Currently, North America is leading the global market due to the increasing number of government reforms and the rising demand for quality healthcare services. Researchers anticipate this regional market to remain on the top over the forthcoming years, thanks to the advent of incentive-based payment methods are their increasing adoption in healthcare organizations.

With a large pool of regional and multinational participants, the global market for patient engagement solutions is highly competitive and fragmented in nature. Athenahealth Inc., GetWellNetwork Inc., Emmi Solutions LLC, McKesson Corp., Cerner Corp., Medecision Inc., Phytel Inc., Axial Exchange, Orion Health, and Allscripts Inc. are the key players operating in this market. These players are focusing on expanding their businesses across various regions in order to strengthen their position in the global market.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4506

Dental Chair Market to Become Worth US$551.8 mn by 2022

According to a research report by Transparency Market Research (TMR), before the finish of 2017, the overall market for dental chairs is relied upon to achieve US$455.5 mn. Further, the open door in this market is anticipated to ascend at a CAGR of 3.90% over the period from 2017 to 2022 and increment to US$551.8 mn before the finish of the figure time frame. The expanding mindfulness among individuals about general oral wellbeing and cleanliness is likewise anticipated that would drive the development of this market throughout the following couple of years. Europe has surfaced as the main local market for dental chairs. Making a flat out chance of US$27.9 mn amid the period from 2017 to 2022, this provincial market is expected to stay on the best finished the following couple of years. The interest for oral surgery dental chairs is moderately higher, at present, and is foreseen to remain so finished the following couple of years. In any case, the interest for different kinds of dental chairs is likewise expanding consistently, around the world.

Read Report Overview: https://www.transparencymarketresearch.com/dental-chairs-market.html

Rise in Geriatric Population Anticipated to Support Growth of Dental Chair Market

With the colossal ascent in the predominance of oral (gum and teeth) ailments over the world, the worldwide dental chair is encountering a wonderful surge in its valuation and size. The headways in the therapeutic and medicinal services infrastructural, around the world, is likewise impelling the development of this market generously. In any case, the lack of ergonomic highlights may confine the selection of these chairs, considering contrarily their deals and, in this way, on the market in the years to come. In any case, the advanced innovation and the rising awareness level of individuals relating to the general oral wellbeing and cleanliness is anticipated to help this market throughout the following couple of years. One of the impediments of the dental calling has been its reliance on settled hardware, for example, the dental units or chairs.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20573

Rise in Disposable Income to Propel Worldwide Dental Chair Market

The dental units for the most part require interfacing with electrical, and additionally seepage and pipes systems. Transportation to the dental office is referred to by a significant number of the elderly as a boundary to dental treatment. The elderly populace is quickly developing on the planet. It is evaluated that 3.5 million US elderly individuals will live in long haul mind offices by year 2030. In a few circumstances, transport framework may likewise limit access to mind. Versatile (transport dental join together) or convenient administrations take out the transportation hindrance by conveying the support of the customer. The convenient dental chair will give more noteworthy help to crippled customers living in those distant spots. They make it workable for the elderly to get the care they merit. The versatile and convenient dental administrations will likewise empower look after the elderly in their homes or care offices. The interest for dental care will keep on increasing.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20573

The worldwide dental chairs market is portrayed by mechanical developments. The key partnerships among global and household organizations is another rising pattern in this market. The main providers of dental chairs over the world, for example, A dec Inc., Danaher, Dexta Corp., DentalEZ Inc., Dome Inc., are progressively including into mergers, acquisitions, and strategic organizations with an end goal to fortify their solid footing in the worldwide market. Throughout the following couple of years, the market is expected to witness extraordinary contention between the sellers, competing based on advancement in items and value differentiation. Leading organizations working in the market were painstakingly profiled by the examination experts, contemplating different viewpoints, for example, upcoming advancements, item portfolio, critical business systems, SWOT investigation, and friends and monetary review.